Role of eosinophil-chemotactic C-C chemokines in cutaneous inflammation

Journal of Leukocyte Biology

Volumn 59, Issue 1, 1996, Pages 1-5

  Schröder, Jens M ^a   Noso, Norio ^a   Sticherling, Michael ^a   Christophers, Enno ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Atopy; Eosinophil; Interleukin 8; RANTES

Indexed keywords

CHEMOTAXIN; EOSINOPHIL CHEMOTACTIC FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEPARIN; INTERLEUKIN 8;

ATOPY; CHEMOTAXIS; EOSINOPHIL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PRIORITY JOURNAL; REVIEW; SKIN INFLAMMATION; T LYMPHOCYTE;

EID: 0030020508     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.59.1.51     Document Type: Review

References (24)

1. Leiferman, K.M. (1991) A current perspective on the role of eosinophils in dermatologic diseases. J. Am. Acad. Dermatol. 24, 1101-1112.
2. Kameyoshi, Y., Dörschner, A., Mallet, A.I., Christophers, E., Schröder, J.-M. (1992) Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J. Exp. Med. 176, 587-592.
3. Dahinden, C.A., Geiser, T., Brunner, T., Tscharner, V.v., Caput, D., Ferrara, P., Minty, A., Baggiolini, M. (1994) Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine. J. Exp. Med. 179, 751-756.
4. Noso, N., Proost, P., Van Damme, J., Schroder, J.-M. (1994) Human monocyte chemotactic proteins-2 and 3 (MCP-2 and MCP-3) attract human eosinophils and desensitize the chemotactic responses towards RANTES. Biochem. Biophys. Res. Commun. 200, 1470-1476.
5. Wang, J.M., Rambaldi, A., Biondi, A., Chen, Z.G., Sanderson, C.J., Mantovani, A. (1989) Recombinant human interleukin 5 is a selective eosinophil chemoattractant. Eur. J. Immunol. 19, 701-708.
6. Owen, W.F., Rothenberg, M.E., Silberstein, D.S., Gasson, J.C., Stevens, R.L., Austen, K.F., Soberman, R.J. (1907) Regulation of human eosinophil viability, density, and functional activity by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts. J. Exp. Med. 166, 129-137.
7. Wardlaw, A.J., Moqbel, R., Cromwell, O., Kay, A.B. (1986) Platelet activating factor. A potent chemotactic and chemokinetic factor for eosinophils. J. Clin. Invest. 78, 1701-1706.
8. Schwenk, U., Morita, E., Engel, R., Schröder, J.-M. (1992) Identification of 5-oxo-15-hydroxy-6,8,11,13-eicosatetraenoic acid (5-oxo-15-HETE) as a novel and potent human eosinophil chemotactic eicosanoid. J. Biol. Chem. 267, 12482-12488.
9. Schwenk, U., Schröder, J.-M. (1995) 5-Oxo-eicosanoids are potent eosinophil chemotactic factors: functional characterization and structural requirements. J. Biol. Chem. 270, 15029-15038.
10. Rot, A. (1993) Chemokines link the two steps of leukocyte adhesion to endothelium. Immunologist 1, 145-149.
11. Schröder, J.-M., Mrowietz, U., Morita, E., Christophers, E. (1987) Purification and partial biochemical characterization of a human monocyte-derived neutrophil-activating peptide that lacks interleukin 1 activity. J. Immunol. 139, 3474-3483.
12. 2-terminal aminoacid sequence-identity with melanoma growth stimulatory activity (MGSA/gro). J. Exp. Med. 171, 1091-1100.
13. Schröder, J.-M. (1994) Neutrophil function-inhibiting proteins in psoriasis. In: Challenges of Modern Medicine, Vol. 3, Molecular Basis of Inflammation (J. Navarro, ed) Ares Serono Symposia Publications, Rome, 239-252.
14. Bruijnzeel, L.B., Kuijper, P.H.M., Rihs, S., Betz, S., Warringa, R.A.J., Koenderman, L. (1993) Eosinophil migration in atopic dermatitis. I: Increased migratory responses to N-formyl-methionyl-leucyl-phenylalanine, neutrophil-activating factor, platelet-activating factor and platelet factor 4. J. Invest. Dermatol. 100, 137-142.
15. Schröder, J.-M., Gregory, H., Young, J., Christophers, E. (1992) Neutrophil activating proteins in psoriasis. J. Invest. Dermatol. 98, 241-247.
16. Schröder, J.-M. (1992) Generation of NAP-1 and related peptides in psoriasis and other inflammatory skin diseases. Cytokines 4, 54-76.
17. Ying, S., Taborda-Barata, L., Meng, Q., Humbert, M., Kay, A.B. (1995) The kinetics of allergen-induced transcription of messenger RNA for monocyte chemotactic protein-3 and RANTES in the skin of human atopic subjects: relationship to eosinophil, T cell, and macrophage recruitment. J. Exp. Med. 181, 2153-2159.
18. Schall, T.J., Jongstra, J., Dyer, B.J., Jorgensen, J., Clayberger, C., Davis, M.M., Krensky, A.M. (1988) A human T cell-specific molecule is a member of a new gene family. J. Immunol. 141, 1018-1025.
19. + human peripheral blood lymphocytes are potent sources of macrophage inflammatory protein 1α, interleukin-8 and RANTES. Eur. J. Immunol. 25, 751-756.
20. Noso, N., Kameyoshi, Y., Neumann, C., Christophers, E., Schröder, J.-M. (1995) Identification of a novel eosinophil-chemotactic cytokine in supernatants of atopic dermatitis skin derived T-lymphocytes. Arch. Derm. Res. 287, 394 (abstract).
21. Rathanaswami, P., Hachicha, M., Sadick, M., Schall, T.J., McColl, S.R. (1993) Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts. J. Biol. Chem. 268, 5834-5841.
22. Sticherling, M., Küpper, M., Koltrowitz, F., Bomscheuer, E., Kulke, R., Klinger, M., Wilhelm, D., Kameyoshi, Y., Christophers, E., Schröder, J.-M. (1995) Detection of chemokine RANTES in stimulated human dermal fibroblasts. J. Invest. Dermatol. 105, 585-591.
23. Kulke, R., Yilmaz, T., Küpper, M., Schlüter, C., Opdenakker, G., Christophers, E., Schröder, J.-M. (1995) Expression of eosinophil specific chemokines in dermal and epidermal cells. J. Invest. Dermatol. 105, 506 (abstract).
24. MacKay, E. (1995) Molecular cloning and characterization of a novel chemokine and receptor that function in eosinophil chemotaxis. J. Leukoc. Biol , in press.